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ticular, lysosomal cysteine proteases with restricted cellu-
lar expression patterns have been the recent focus of at-
tention of the pharmaceutical industry (Leung-Toung
et al., 2002). One would certainly hope that drugs devel-
oped against proteases with restricted expression would
have fewer side effects. On the other hand, redundancy
within this family of enzymes may reduce the effective-
ness of inhibitor therapy. 
Clearly, redundancy (but also diversity) can occur at
multiple levels: genetic, structure-function related and
cellular, leading to the generation of multiple scenarios by
which cysteine proteases could exert specific functions.
Functional redundancy can be reduced, for example, if
individual genes with the same function become increas-
ingly tissue-specific due to unselected mutations in the
promoters. The idea that redundancy affects our inter-
pretation of gene structure and function is hardly new,
however, the extent of potential redundancy in humans
has become apparent only recently with the analysis of
the whole genome revealing large gene numbers for cer-
tain families.
Despite recent advances regarding novel protease se-
quences, the in vivo roles of these enzymes are largely
unknown. Here we describe the current understanding of
the genetic, structural and functional similarities and dif-
ferences of lysosomal cysteine proteases in view of their
possible overlapping biological activities. While genetic
and molecular redundancy is well documented for this
family of enzymes, evidence is accumulating that func-
tional redundancy does not play a major role. In particu-
lar, characterization of gene knockouts has revealed spe-
cific functions for individual enzymes, indicating that
overlapping biological functions may be very limited.
Genetic Diversity or Redundancy?
Sequence homologies of cathepsins B, C, H and L sup-
port the view that these enzymes diverged early during
eukaryotic evolution (Berti and Storer, 1995). The cathep-
sin B lineage evolved in primitive eukaryotic cells, prior to
the divergence of plant and animal kingdoms and under-
scores the diversity of cellular functions that members of
this enzyme family facilitate. A cathepsin B-like enzyme
found in protozoan parasites of the genus Giardia repre-
sents the earliest branch of the cathepsin B subfamily
(Ward et al., 1997). Interestingly, attempts to identify se-
cretory digestive enzymes in nematodes revealed a large
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Recent progress in the identification and partial char-
acterization of novel genes encoding cysteine pro-
teases of the papain family has considerably in-
creased our knowledge of this family of enzymes.
Kinetic data available to date for this large family indi-
cate relatively broad, overlapping specificities for
most enzymes, thus inspiring a growing conviction
that they may exhibit functional redundancy. This is
also supported in part by phenotypes of cathepsin
knockout mice and suggests that several proteases
can substitute for each other to degrade or process a
given substrate. On the other hand, specific functions
of one particular protease have also been document-
ed. In addition, differences in cellular distribution and
intracellular localization may contribute to defining
specific functional roles for some of these proteases. 
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Introduction
Our knowledge of proteolytic enzymes has grown consid-
erably in the last decade. The classical view of lysosomal
protease function has shifted recently from nonspecific
protein degradation and turnover within the endosomal/
lysosomal system toward more specific functions
through limited proteolysis of both intra- and extracellular
substrates. In addition to their contribution to normal
physiological processes, it has been clearly demonstrat-
ed that cysteine proteases play a role in various patholog-
ical conditions (reviewed for example by Koblinski et al.,
2000; Brömme and Kaleta, 2002). Therefore, cysteine
proteases are presently viewed as attractive drug targets
for a number of diseases, e.g. osteoporosis, rheumatoid
arthritis, inflammatory and autoimmune diseases. In par-
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family of cathepsin B-like genes which seem to be devel-
opmentally regulated, occurring only in adult worms of
Haemonchus contortus and other nematode species
such as C. elegans (Rehman and Jasmer, 1999; Jasmer
et al., 2001). Sequence variability of cathepsin B-like en-
zymes, in particular in the occluding loop region and
residues forming the S2 and S2’ subsites, suggests sub-
stantial functional diversity in enzymatic properties of
nematode cathepsin B-like enzymes. Since these
cathepsin B-like sequences do not have orthologous
counterparts in higher animals, it can be assumed that
they were lost during evolution either due to functional re-
dundancy or to differences in the digestive system in
higher animals. A further early divergence of family C1
proteases led to enzymes closely related to cathepsins F
and X in nematodes. Cathepsin X from the nematode On-
chocerca volvulus (sharing 65% sequence identity with
the human enzyme) is apparently involved in molting of
third stage larvae (Lustigman et al., 1996).
Additional cathepsin sequences appear in mammalian
genomes, most likely as a result of gene duplication or
gene multiplication events. A subfamily of placentally ex-
pressed cathepsins (cathepsins M, P, Q, R, 1, 2, 3 and 6),
closely related to cathepsin L, were shown to be present
in mice (clustered on chromosome 13) and partly also in
rats. However, orthologs of these genes were not found
in human or rabbit placenta (Mason et al., 2002). An addi-
tional (partial) gene duplication event within the same re-
gion of chromosome 13 (in mice) may have led to the
genes encoding the cytotoxic T lymphocyte-associated
proteins 2α (Ctla-2α) and β (Ctla-2β) with high homology
to the proregion of papain-like cysteine proteases (Deni-
zot et al., 1989). Rapid rates of divergence, as seen for
the placentally expressed cathepsins, could act to gener-
ate functional diversity. The unique active site clefts of the
placenta-specific enzymes support this idea (Sol-Church
et al., 2002). On the other hand, these cathepsins are
evolutionarily unstable and most likely were lost in hu-
mans. Therefore, a certain degree of redundancy among
placentally expressed cathepsins cannot be excluded.
Within the human genome, some of the genes encod-
ing more recently identified enzymes may be the result of
tandem gene duplication events as suggested by three
pairs of genes with the same chromosomal location, high
sequence homologies and the precise conservation of
several intron splice sites (Gelb et al., 1997): cathepsins K
and S are colocalized at the chromosomal region 1q21,
cathepsins V and L at 9q22 and cathepsins F and W at
11q13, respectively (Figure 1). One explanation is that
duplication offered an opportunity for the acquisition of
new roles by recruitment to new specific sites of expres-
sion, coupled with partial redundancy by retention of the
ancestral site. Indeed, in all three cases, at least one of
the proteases localized to the same chromosomal region
displays a somewhat restricted expression pattern.
Cathepsin K is predominantly expressed in osteoclasts
(Brömme and Okamoto, 1995), cathepsin V in the thymus
and testis (Brömme et al., 1999), and cathepsin W in cy-
totoxic T cells (Linnevers et al., 1997). Such specific ex-
pression in a certain cell type or tissue may be related to
a specific function of that protease in the particular cell
type or tissue and therefore may contribute to diversity. In
addition to the eleven cathepsins harboring a functional
active site, the human genome contains at least three
cathepsin L-like and two TIN antigen-related non-pro-
tease homologs (Figure 1).
In addition to the gene level, diversity may also be in-
troduced downstream at the transcriptional or transla-
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Fig. 1 Chromosomal Localization of Human Papain-Like Cysteine Proteases.
The positions corresponding to genes encoding the 11 known cathepsins are indicated: cathepsin B (CTSB, 8p22), dipeptidyl pepti-
dase I (cathepsin C, CTSC, 11q14), cathepsin F (CTSF, 11q13), cathepsin H (CTSH, 15q24-q25), cathepsin K (CTSK, 1q21), cathepsin
L (CTSL, 9q21-q22), cathepsin O (CTSO, 4q31), cathepsin S (CTSS, 1q21), cathepsin V (CTSL2, 9q22), cathepsin W (CTSW, 11q13),
and cathepsin X (CTSZ, 20q13). Non-protease homologs are marked with an asterisk: TIN antigen-related (LCN7, 1p34), TIN antigen
(TINAG, 6p11-p12), cathepsin L-like pseudogene 1 (CTSLL1, 10q) cathepsin L-like proteinase 2 (CTSLL2, 10q), cathepsin L-like pro-
teinase 3 (CTSLL3, 10q22-q23). The gene names and locus positions are from LocusLink (National Center for Biotechnology Informa-
tion). The common names used throughout this review are from MEROPS (Rawlings et al., 2002).
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tional level. It is a well-known fact that the number of pro-
teins in the proteome is by no means equivalent to the
number of genes, but can exceed it significantly. A mech-
anism widely used to enhance protein diversity is alterna-
tive splicing. Within the papain family, this phenomenon
has been described for cathepsins B, C, H and L (Berquin
et al., 1995; Rescheleit et al., 1996; Matsui et al., 2002;
Waghray et al., 2002), but chances are that splice variants
will also be detected for some of the more recently dis-
covered enzymes. The physiological role of cathepsin
splice variants is unclear. There is some indication that
human cathepsin B and H splice variants could be tumor-
related mRNAs, since they are highly expressed in trans-
formed cells (Berquin et al., 1995; Waghray et al., 2002).
In addition, cathepsin B alternative splice forms have
also been described in rheumatoid synovium and in os-
teoarthritic cartilage (Lemaire et al., 1997; Berardi et al.,
2001).
Structural Aspects
Structural and functional aspects of mature enzymes and
of cysteine protease precursors were reviewed recently
(Groves et al., 1998; Bühling et al., 2000; Turk et al.,
2001a). A high degree of variability is found among the
proregions of cysteine proteases, not only with regard to
the amino acid sequence, but also with regard to the
length varying from 38 residues in cathepsin X to 251
residues in cathepsin F. While most cysteine proteases
for which the structures are known are inhibited by their
proregions through noncovalent blocking of the active
site, a novel mode of inhibition through covalent binding
to the active site cysteine has been described for cathep-
sin X (Sivaraman et al., 2000). Regarding the mature en-
zymes, several structures of cysteine proteases of the
papain family have been solved and all share a common
fold. This is due to the fact that the papain-like enzymes
probably evolved from the same basic endopeptidase
structural platform. Enzymes able to function ‘by design’
as exopeptidases contain additional structural features
that limit access to the active site and confer exopepti-
dase capability to them: cathepsin H and DPP-I (dipep-
tidyl peptidase I, cathepsin C) display aminopeptidase
activities due to additional sequences that act as anchors
for the N-terminal amino group of a substrate (Guncar
et al., 1998; Olsen et al., 2001; Turk et al., 2001b).
Cathepsins B and X possess insertion loops partially oc-
cluding the binding cleft beyond the S2’ and S1’ subsite,
respectively (Musil et al., 1991; Sivaraman et al., 2000).
These loops, which contain amino acid residues able to
interact with the C-terminus of a substrate, are the major
structural determinants of the carboxypeptidase speci-
ficity. Therefore, despite similar folds, the structural dif-
ferences both within the proregions and the mature en-
zymes are likely to limit functional redundancy of cysteine
proteases. 
It must be noted that the consequences of structural
differences within the proregions of cysteine proteases
are less clear. Although the majority of the human en-
zymes have proregions of approximately 100 amino acid
residues, i.e. procathepsins H, K, L, S, V and W, there is
little sequence identity within these segments (Figure 2).
Among the members for which the structure of the zymo-
gens has not been determined, procathepsins C and O
are particularly interesting, since they do not possess the
ERFNIN motif (a conserved sequence motif involved in
restraining the 3D arrangement of the proregion domain
for several cathepsin precursors; Coulombe et al., 1996;
Groves et al., 1998), and display poor sequence identities
with other cathepsin proregions. However, despite the
lack of sequence identity, very good overall structural
similarity exists between the proregions of procathepsins
B and L (reviewed in Cygler and Mort, 1997). Regarding
cathepsin F, it will be interesting to find out if the prore-
gion does contain a cystatin-like domain, as predicted
(Nägler et al., 1999a). Structural differences within the
proregions may lead to different activation mechanisms
and may affect the individual regulation for a given en-
zyme. 
Examples of Functional Diversity 
In contrast to other cysteine protease families with strict
specificities such as caspases, lysosomal cysteine pro-
teases are characterized by relatively broad, overlapping
specificities. The nature of the residue at position P2 of a
substrate is in many cases the most significant specifici-
Redundancy of Cathepsins 839
Fig. 2 Sequence Identities (in %) of Human Papain-Like Cys-
teine Proteases.
Upper right: mature enzymes; bottom left: proregions. Identities
were calculated using a structure-based alignment of cathep-
sins B, K, L and X followed by CLUSTAL W alignment of the re-
maining sequences and minor manual adjustments.
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ty determinant (Storer and Ménard, 1996). Interestingly,
typical endopeptidases (e.g. cathepsin K or L) can also
display exopeptidase activity (Nägler et al., 1999b). In
some cases, the activity is even equal or greater than that
measured with the ‘true’ exopeptidase. Similarly, ex-
opeptidases such as cathepsins B or C can also act as
endopeptidases. A notable exception is cathepsin X,
which seems to be a strict exopeptidase (Nägler et al.,
1999c). As observed for the normal endopeptidase activ-
ity, the exopeptidase activities of enzymes known as
‘classical’ endopeptidases rely heavily on interactions in
subsite S2 (and possibly S1). Exopeptidases, however, are
able to hydrolyze substrates through the exopeptidase
route even in the absence of preferred interactions in
subsites S2 and S1. Whether this in vitro redundancy in
positional specificity is relevant in vivo largely depends
on the sequence around the C- or N-terminus of the sub-
strate. On the other hand, this mechanistic redundancy
will most likely be overruled in vivo by a different cellular
localization of protease and substrate or by the presence
of another (more efficient or more abundant) protease.
In addition to general protein degradation in endoso-
mes/lysosomes, cysteine proteases have been associat-
ed with many different more or less specialized proteolyt-
ic processes such as activation of zymogens, invariant
chain and antigen processing or hormone activation.
Several examples can illustrate the complexity of lysoso-
mal cysteine protease function.  
Cathepsins L, S, and F have been implicated in invari-
ant chain (Ii) processing and MHC class II loading with
antigenic peptides (reviewed in Nakagawa and Rudensky,
1999; Villadangos and Ploegh, 2000). Cathepsin L was
found to be necessary for Ii degradation in cortical thymic
epithelial cells, but not in bone marrow-derived antigen-
presenting cells (Nakagawa et al., 1998), whereas cathep-
sins S and F were shown to process Ii in B cells and
macrophages, respectively (Riese et al., 1996; Shi et al.,
2000). After binding to antigenic peptides, class II mole-
cules are presented at the cell surface for recognition by
CD4+ T cells. The knowledge of proteases involved in
MHC class II antigen presentation in a tissue-specific
manner suggests a potential way of manipulating CD4+ T
cell responsiveness in vivo. From the literature data avail-
able, a reasonable guess might be that these proteases
possibly possess overlapping but complementary speci-
ficities for efficient processing of the invariant chain and of
each antigen. Proteases belonging to other classes, in
particular aspartic proteases, might be necessary as well
in antigen presentation. MHC class II-restricted antigen
presentation to CD4+ T cells is achieved by an essentially
common pathway that is subject to variation with regard
to the location and extent of degradation of protein anti-
gens and the site of peptide binding to MHC class II mole-
cules. These variations reveal a surprising diversity which
may have profound consequences for the induction of im-
munity to infection and tumors as well as autoimmunity
(reviewed in Robinson and Delvig, 2002). 
The best documented role of proteases in bone re-
sorption processes is the solubilization of the bone ma-
trix. Accumulating evidence indicates that proteases may
determine whether resorption will be followed by bone
formation. Among the identified proteases involved in
these different steps, cathepsin K, which is selectively
expressed in osteoclasts, plays a key role. Cathepsin K
efficiently degrades type I collagen, which represents al-
most 90% of the organic bone matrix (Bossard et al.,
1996). When compared with other cathepsins, cathepsin
K was also found to be the most potent elastinolytic en-
zyme (Chapman et al., 1997). In addition, direct evidence
supporting the participation of cysteine proteases in
bone resorption was provided by the demonstration that
specific cysteine protease inhibitors block this process in
cultures of explanted bones or isolated osteoclasts as
well as in vivo (reviewed in Delaisse et al., 2000). The role
of cathepsin K in bone remodeling is also clearly demon-
strated in gene knockout experiments (see below).
Cysteine proteases are able to mediate proteolytic ac-
tivation or degradation of hormones and cytokines. For
example, cathepsins B, L, and K mediate the processing
of thyroglobulin by limited extracellular proteolysis at the
apical plasma membrane, thereby rapidly liberating thy-
roxin (Tepel et al., 2000). Inactivation through degradation
by cathepsins has also been documented. Inhibition of
endosomal insulin-like growth factor I (IGF-I) processing
by cysteine protease inhibitors profoundly altered recep-
tor trafficking and signaling. In E-64 and CA074-methyl
ester-treated human breast and murine lung carcinoma
cells intracellular ligand degradation was blocked, sug-
gesting that ligand processing by endosomal peptidases
is a key step in receptor signaling and function (Navab
et al., 2001).
Gene Knockout Studies
Many cathepsin gene knockout mouse strains do not
show a dramatically changed phenotype, thus leading to
speculations regarding functional redundancy. On the
other hand, targeted inactivation of individual cathepsins
has provided valuable information on the biological func-
tion of the respective gene. In particular phenotypes of
mice deficient in cathepsin B or L have been investigated
in detail (reviewed in Reinheckel et al., 2001). 
Cathepsin B-deficient mice cannot be distinguished
from their wild-type counterparts, therefore suggesting
that another protease may be able to substitute at least in
part for cathepsin B (Halangk et al., 2000). However, upon
induction of pancreatitis in cathepsin B-deficient mice,
the trypsin activity in the pancreas was more than 80%
lower as compared to wild-type animals, indicating a role
for cathepsin B in intrapancreatic trypsinogen activation
and the onset of acute pancreatitis. Cathepsins B and L
are required for integrity of the postnatal central nervous
system. Combined deficiency of cathepsins B and L in
mice is lethal during the second to fourth week of life.
Cathepsin B/L double knockout mice exhibit severe brain
840 D.K. Nägler and R. Ménard
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atrophy and selective neuronal vulnerability with rapid
loss of neurons due to massive apoptosis of neurons in
the cerebral cortex (Felbor et al., 2002). Interestingly,
even though cathepsins B and L are expressed in all or-
gans, only the brain was severely affected.
Mice lacking cathepsin L develop periodic hair loss
due to alterations of hair follicle morphogenesis and cy-
cling (Roth et al., 2000). Furthermore, cathepsin L plays a
role in immune reactions in that it regulates CD4+ T cell
selection and mediates invariant chain processing in cor-
tical thymic epithelial cells (Nakagawa et al., 1998; Honey
et al., 2002). Within one year, cathepsin L-deficient mice
develop additional pathomorphological, histological and
functional alterations that closely resemble human dilat-
ed cardiomyopathy (Stypmann et al., 2002). Unfortunate-
ly, the human ortholog of murine cathepsin L seems to be
cathepsin V and not cathepsin L (Brömme et al., 1999).
Therefore, the functions identified for mouse cathepsin L
may be different from the role played by either cathepsin
V or L in humans. Based on these findings, a certain re-
dundancy among these two cathepsins cannot be ex-
cluded.
Cathepsin S controls the trafficking and maturation of
MHC class II molecules in antigen-presenting cells (Nak-
agawa et al., 1999). Mice lacking cathepsin S demon-
strate a profound inhibition of Ii degradation in antigen-
presenting cells in vivo. Diminished susceptibility to
collagen-induced arthritis in cathepsin S-deficient mice
suggests a potential role in the regulation of immune re-
sponsiveness. On the other hand, cathepsin B is not es-
sential for MHC class II-mediated antigen presentation
(Deussing et al., 1998).
Loss-of-function mutations in the human dipeptidyl
peptidase I (cathepsin C) gene have been associated
with Papillon-Lefèvre syndrome, an autosomal recessive
disorder that causes palmoplantar hyperkeratosis and
periodontitis (Toomes et al., 1999). How the absence of
cathepsin C activity produces the symptoms of Papillon-
Lefèvre syndrome is currently unknown. However, stud-
ies in knockout mice suggest that it may be due in part to
altered serine protease activity, since the processing and
activation of granzymes A and B requires cathepsin C in
vivo (Pham and Ley, 1999). Thus, cathepsin C-knockout
cytotoxic T cells contain normal amounts of granzymes A
and B, but these molecules retain their prodipeptide do-
mains and are inactive. Moreover, cathepsin C may also
be necessary for serine protease processing in mast
cells, in particular for the activation of tryptases and chy-
mases (Sakai et al., 1996; Wolters et al., 2001).
Cathepsin K-deficient mice survive and are fertile, but
display an osteopetrotic phenotype with excessive tra-
beculation of the bone-marrow space (Saftig et al., 1998).
In particular, the resorptive activity of cathepsin K-defi-
cient osteoclasts is severely impaired, supporting the hy-
pothesis that cathepsin K is of major importance in bone
remodeling. In humans, cathepsin K deficiency causes
pycnodysostosis, an autosomal recessive osteochon-
drodysplasia, consistent with its expression in osteo-
clasts and function in bone resorption (Gelb et al., 1996;
Saftig et al., 1998).
Conclusion
It is now widely recognized that cysteine proteases, act-
ing either alone or in a concerted fashion and often
through limited proteolysis, can contribute to specialized
cellular functions. They are also able, as has been known
for several years, to contribute to the complete degrada-
tion of proteins within the endosomal/lysosomal system.
In addition, these enzymes might participate in other, yet
unknown, processes and the challenge within the next
few years will be to identify physiological and pathophys-
iological substrates for this class of proteases. Predomi-
nant expression of cathepsin K in osteoclasts and its well
documented role in bone remodeling makes cathepsin K
an interesting target for the pharmaceutical industry. In
particular, its involvement in osteoporosis has led to pre-
clinical and lately to clinical trials of cathepsin K inhibitors
(Leung-Toung et al., 2002). Cathepsin S, another pro-
tease with restricted tissue expression, is regarded as a
potential target in inflammatory and autoimmune dis-
eases.
In summary, the apparent redundancy of papain-like
cysteine proteases is significantly reduced due to a differ-
ent cellular localization of highly homologous enzymes,
incorporation of additional domains (as in cathepsin F) or
different specificities of co-localized enzymes. However,
one still needs to pose new biological-physiological
questions, and to probe deeper into the physiology of
cells – in this case, the various ways in which proteolytic
activation cascades and protein catabolism work in a cer-
tain cell type.
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